Group 1 - Shanghai Aoyi Information Technology Co., Ltd. (Aoyi Technology) has completed a nearly 100 million yuan B++ round of financing, led by Infinity Capital, Zhejiang State-owned Capital Operation Co., Ltd., and Womeda Capital [1][3] - This financing follows a previous B+ round completed three months ago, which raised nearly 100 million yuan, led by Huafa Group and supported by several other investors [1][3] - Aoyi Technology focuses on the intersection of brain science and robotics, developing a platform that integrates "neural interfaces, robotics, and AI algorithms" [1][5] Group 2 - The funds from the latest financing will be used to accelerate the R&D of dexterous hand technology, promote the launch of new dexterous hand products, and expedite the market introduction of finger joint exoskeleton robots [3][5] - Aoyi Technology aims to establish an internationally leading standardized production system to optimize production processes and achieve a 100% increase in annual production capacity [3][5] - The dexterous hand is a key component for robots to simulate human hand movements and has become a focal point in the capital market and robotics industry [3][4] Group 3 - Current challenges in the dexterous hand market include balancing hardware and software requirements, with high degrees of freedom and precision leading to increased costs and complexity [4] - Aoyi Technology has successfully iterated multiple versions of its dexterous hand products since 2017, with the new generation ROH-AP001 expected to launch by the end of May, featuring tactile and pressure sensing capabilities [5][6] - The company has over 80 patents and has developed various products, including the OHand series of intelligent bionic hands, which have gained significant market share due to their performance and cost-effectiveness [5][6]

文｜胡香赟 编辑｜海若镜 36氪获悉，「傲意科技」近期已完成近亿元B++轮融资。本轮融资由英飞尼迪资本、浙江省国有资本运营有限公司旗 下浙江省发展资产经营有限公司、沃美达资本共同投资，升氪剂资本担任长期财务顾问。 据了解，这也是傲意科技继今年初的亿元级B+轮融资后，在3个月内再次快速交割的一笔新融资。本轮募集资金将用 于加速灵巧手技术领域的研发投入、推动新产品上市进程，以及产能建设和市场拓展等。 傲意科技成立于2015年，专注于机器人与脑科学的技术研发，并搭建了"机器人-AI算法-神经接口"三位一体的自主研 发平台。 目前，包括面向具身机器人与工业自动化场景的ROhand系列灵巧手、面向截肢患者的OHand™智能仿生手、以及面向 由于神经功能损伤导致的手部运动障碍的手指关节外骨骼产品三大类核心产品在内，傲意科技已有多款手型机器人产 品上市销售。 傲意科技创始人倪华良表示，在手型机器人产品开发上，无论是具身场景还是医疗场景，除了系统参数和系统稳定性 要求之外，成本也是一个需要被兼顾到的重要问题。这也是公司自创立之初，就力求通过自研算法和核心零部件，寻 找有别于海外高价产品的"成本最低的解决方案"的原因。 以OH ...